AgomAb Therapeutics NV American Depositary Shares Financial Flexibility Index
AgomAb Therapeutics NV American Depositary Shares financial flexibility index. AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Financial Flexibility Index of -0.65x as of March 2026. Free cash flow of $-12.07 Million (operating CF $-12.44 Million minus capex $363.00K) represents -1% of total liabilities ($18.70 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of AgomAb Therapeutics NV American Depositary Shares (2022–2025)
Financial flexibility index of AgomAb Therapeutics NV American Depositary Shares from 2022 to 2025. Historical Financial Flexibility Index trend for AgomAb Therapeutics NV American Depositary Shares across 4 annual periods. Explore AgomAb Therapeutics NV American Deposita cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
AgomAb Therapeutics NV American Depositary Shares Financial Flexibility Index by Year (2022–2025)
AgomAb Therapeutics NV American Depositary Shares financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for AgomAb Therapeutics NV American Depositary Shares. For the full cash flow conversion analysis, see AGMB operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.27x | $-51.74 Million | $-51.74 Million | $22.80 Million | ▲ +10.2% |
| 2024 | -2.53x | $-46.15 Million | $-46.83 Million | $18.28 Million | ▼ -103.6% |
| 2023 | -1.24x | $-24.59 Million | $-24.59 Million | $19.82 Million | ▼ -127.3% |
| 2022 | -0.55x | $-18.97 Million | $-18.97 Million | $34.75 Million | — |